An interventional study of tDCS in Motor Activity, sponsored by Indiana University. Terminated at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Indiana University · Not applicable, Interventional, and Treatment
Interim study results were not favorable to continue with further enrollment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Motor Activity by Indiana University — 3 open to participants now, 3 under way, none of them phase 3. Motor Activity · Indiana University.
Among the 14 studies in Motor Activity by Indiana University, this one is the 9th largest by enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 11 with no phase, and was the 13th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →3 of the 14 studies in Motor Activity by Indiana University are open now, in 1 country. Recruiting first, the newest first:
Indiana University · Sites in United States
Ages 55–85
Indiana University · Sites in United States
Ages 35–75
Indiana University · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 1977; this study’s year is marked. 2 started in 2025.
This study's enrollment of 40 is below the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 60 across the 13 interventional studies, 60 across the 1 observational. Of the 11 that completed or were terminated, 3 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
Indiana University is the lead sponsor of 991 studies on the registry; 202 are open to participants now.
Of its 150 completed or terminated interventional studies of FDA-regulated products, 118 (79%) have results posted.
1 of the studies in Motor Activity by Indiana University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06886906Indiana UniversityExploring the Acute and Dynamic Relationships Between Movement and Pain in Older Adults With Musculoskeletal Pain | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 14 studies in Motor Activity by Indiana University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the simultaneous coordination of both hands. The study will utilize a between-subjects, SHAM controlled design. Subjects will be randomly selected to receive either SHAM (n=26) or a-tDCS (n=26) stimulation and will be blinded to their condition throughout testing. Subjects will complete a total of two testing sessions, separated by \~24 hours. Both sessions will have the subject play the videogame "Guitar Hero", with a single song done for several trials as pre- and post-assessments. The first session will contain a 20-minute practice/stimulation block where subjects practice the guitar task while receiving either "active" or "inactive" stimulation of the motor cortex. The first session will last approximately 75 to 90 minutes whereas the second session will last approximately 15 to 20 minutes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Currently prescribed and taking stimulant medication (Adderall, Ritalin, Vyvanse, etc.)
This group will receive 20 minutes of 1 mA tDCS stimulation to the motor cortex while playing the videogame. The total session duration will last approximately 30 minutes and there will be a 30 minutes retention session 24 hours later.
Device: tDCS
This group will receive 30 seconds of 1 mA tDCS stimulation to the motor cortex and then it will shut off, effectively serving as a control, while subjects play the videogame for 20 minutes. The total session duration will last approximately 30 minutes and there will be a 30 minutes retention session 24 hours later.
Device: tDCS
Applying tDCS to determine if it facilitates learning of a video game task
Improvement in a Video Game
To determine whether a-tDCS influences motor skill acquisition of a dexterous video game task by measuring the outcome of videogame performance (number of notes played) with and without a-tDCS. The number of correct notes played is the outcome measure- where the greater the number, the better the outcome or performance. All subjects were expected to increase in performance, but the hypothesis was that the performance in the tDCS group would be greater than in sham.
Time frame: 20 minutes- change in number of notes played t2-t1
Retention and Learning
Learning will be measured within-groups by examining retention, or the outcome of video game performance (number of notes played) between the first and second sessions. The number of notes successfully played, where more notes equated to improved outcomes or performance.
Time frame: 24 hours difference in notes between t2-t1
| Milestone | tDCS | SHAM |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
To determine whether a-tDCS influences motor skill acquisition of a dexterous video game task by measuring the outcome of videogame performance (number of notes played) with and without a-tDCS. The number of correct notes played is the outcome measure- where the greater the number, the better the outcome or performance. All subjects were expected to increase in performance, but the hypothesis was that the performance in the tDCS group would be greater than in sham.
| change in number of notes played | tDCS | SHAM |
|---|---|---|
| Improvement in a Video Game | 15.72 ± 7.59 | 15.5 ± 10.73 |
Learning will be measured within-groups by examining retention, or the outcome of video game performance (number of notes played) between the first and second sessions. The number of notes successfully played, where more notes equated to improved outcomes or performance.
| change in number of notes played | tDCS | SHAM |
|---|---|---|
| Retention and Learning | 3.07 ± 3.16 | 2.38 ± 2.91 |
Collected over up to 24 hours. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| tDCS | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| SHAM | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Age, Categorical(Participants) | tDCS | SHAM | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 20 | 20 | 40 |
| >=65 years | 0 | 0 | 0 |
| Age, Continuous(years) | tDCS | SHAM | Total |
|---|---|---|---|
| Mean | 22.8 ± 4.03 | 21.5 ± 1.49 | 22 ± 3.1 |
| Sex: Female, Male(Participants) | tDCS | SHAM | Total |
|---|---|---|---|
| Female | 9 | 9 | 18 |
| Male | 11 | 11 | 22 |
| Race and Ethnicity Not Collected(Participants) | tDCS | SHAM | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Apr 2025 to primary completion in Dec 2025, 7 months.
Results were first posted in Oct 2026, 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
Interim study results were not favorable to continue with further enrollment
Interim study results were not favorable to continue with further enrollment
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.